DR RHIANNON CHALMERS-BROWN : RICE Research Assistant – Low Carbon Bioprocess Analysis I completed my undergraduate degree in Chemistry at USW, I was then encouraged by my research supervisor, Prof Richard Dinsdale, to apply for the KESS 2 scholarship as I had a keen interest in renewable energy and the environmental sector in general. The… Read more »
Case Studies: Chemistry
Developing new chemical and genomic technologies for traceability and quality assurance of edible and industrial vegetable oils
Kirstie Goggin (ESF-funded KESS 2 PhD), was awarded her PhD in an amazing timescale of 3 years 4 months through the KESS 2 Programme, being the first KESS 2 female PhD recipient at USW. KIRSTIE GOGGIN A STUDENT’S PERSPECTIVE My PhD was about developing new chemical and genetic approaches to improve traceability, transparency and authenticity… Read more »
Welsh scientists are helping to keep our food healthy, safe and sustainable
Much of our food in the UK is sourced via often-complex supply chains involving numerous producers and processors from around the world. Unfortunately this can lead to illicit and/or unethical practices as some food ingredients may be contaminated by adulterants or obtained from undesirable sources. Recent examples include the use or horsemeat instead of beef… Read more »
Turning waste gases into renewable products
Rhiannon Chalmers-Brown has returned to study her PhD at the University of South Wales, having initially studied BSc Chemistry at USW. She was encouraged by her research supervisor Richard Dinsdale to apply for the KESS 2 scholarship, as she has a keen interest in renewable energy and the environmental sector in general. Rhiannon started her… Read more »
Development of a novel quinone prodrug delivery system for cancer (Presentation)
The chemotherapy agents which are in current use are highly toxic compounds and are also non selective meaning that in effect the patient is being medically “poisoned” in the hope that the cancer will die first. Prodrug technology allows for the selective deployment of highly toxic drugs into cancer cells, whilst healthy cells are left relatively unaffected.
Read more »